Estimation of endogenous noradrenaline release in rat brain in vivo using [3H]RX 821002

Synapse

Volumn 55, Issue 2, 2005, Pages 126-132

  Tyacke, Robin J ^a   Robinson, Emma S J ^a   Lalies, Maggie D M ^a   Hume, Susan P ^b   Hudson, Alan L ^a   Nutt, David J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Microdialysis; Noradrenaline; PET; 3H RX 821002; 2 adrenoceptors

Indexed keywords

2 (2 IMIDAZOLIN 2 YL)QUINOLINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; AMPHETAMINE; IDAZOXAN; IMIDAZOLINE; LIGAND; NORADRENALIN; SELEGILINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION; BINDING AFFINITY; BRAIN FUNCTION; BRAIN METABOLISM; CINGULATE GYRUS; CONTROLLED STUDY; EMOTION; EXTRACELLULAR SPACE; IN VIVO STUDY; ISOTOPE LABELING; MALE; MEMORY; NONHUMAN; NORADRENALIN RELEASE; POSITRON; PRIORITY JOURNAL; RADIOACTIVITY; RAT; TISSUE DISTRIBUTION;

EID: 10844294216     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20100     Document Type: Article

References (37)

1. Baker GB, Urichuk LJ, McKenna KF, Kennedy SH. 1999. Metabolism of monoamine oxidase inhibitors. Cell Mol Neurobiol 19:411-426.
2. Cenci MA, Kaien P, Mandel RJ, Bjorklund A. 1992. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat. Brain Res 581:217-228.
3. Finn DP, Lalies MD, Harbuz MS, Jessop DS, Hudson AL, Nutt DJ. 2002. Imidazoline(2) (I(2)) binding site- and alpha(2)-adrenoceptor-mediated modulation of central noradrenergic and HPA axis function in control rats and chronically stressed rats with adjuvant-induced arthritis. Neuropharmacology 42:958-965.
4. Glue P, Nutt D. 1990. Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiatry 157:491-499.
5. Gsell W, Jungkunz G, Riederer P. 2004. Functional neurochemistry of Alzheimer's disease. Curr Pharm Des 10:265-293.
6. Harley CW, Lalies MD, Nutt DJ. 1996. Estimating the synaptic concentration of norepinephrine in dentate gyrus which produces beta-receptor mediated long-lasting potentiation in vivo using microdialysis and intracerebroventricular norepinephrine. Brain Res 710:293-298.
7. Heinonen EH, Lammintausta R. 1991. A review of the pharmacology of selegiline. Acta Neurol Scand Suppl 136:44-59.
8. 2-Adrenergic receptors structure, function and therapeutic implications. Amsterdam: Harwood Academic, p 1-18.
9. 2- adrenoceptors in the rat brain. Mol Neuropharmacol 1:219-229.
10. Hudson AL, Gough R, Tyacke R, Lione L, Lalies M, Lewis J, Husbands S, Knight P, Murray F, Hutson P, Nutt DJ. 1999. Novel selective compounds for the investigation of imidazoline receptors. Ann N Y Acad Sci 881:81-91.
11. Hudson AL, Tyacke RJ, Lalies MD, Davies N, Finn DP, Marti O, Robinson E, Husbands S, Minchin MC, Kimura A, Nutt DJ. 2003. Novel ligands for the investigation of imidazoline receptors and their binding proteins. Ann N Y Acad Sci 1009:302-308.
12. 2-adrenoceptors. Nucl Med Biol 19:841-849.
13. Klimek V, Zhu MY, Dilley G, Konick L, Overholser JC, Meltzer HY, May WL, Stockmeier CA, Ordway GA. 2001. Effects of long-term cigarette smoking on the human locus coeruleus. Arch Gen Psychiatry 58:821-827.
14. Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, Brooks DJ, Bench CJ, Grasby PM. 1998. Evidence for striatal dopamine release during a video game. Nature 393:266-268.
15. Lai JC, Leung TK, Guest JF, Lim L, Davison AN. 1980. The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations. Biochem Pharmacol 29:2763-2767.
16. 3H]noradrenaline uptake in rat brain slices. Br J Pharmacol 117:314P.
17. Lalies MD, Hibell A, Hudson AL, Nutt DJ. 1999. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands. Ann N Y Acad Sci 881:114-117.
18. Lalies MD, Hudson AL, Nutt DJ. 2000. Acute peripheral administration of (-)deprenyl elevates extracellular noradrenaline in rat frontal cortex. J Psychopharmacol 14:A35.
19. Lammertsma AA, Hume SP. 1996. Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158.
20. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423-451.
21. 2 receptors. Eur J Pharmacol 353:123-135.
22. Nutt DJ. 2002. The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psychopharmacol 17(Suppl 1):S1-12.
23. Nutt DJ, Pinder RM. 1996. (alpha)2-adrenoceptors and depression. J Psychopharmacol Supplement 35:42.
24. Nutt DJ, French N, Handley S, Hudson A, Husbands S, Jackson H, Jordan S, Lalies MD, Lewis J, Lione L, Mallard N, Pratt J. 1995. Functional studies of specific imidazoline-2 receptor ligands. Ann N Y Acad Sci 763:125-139.
25. Paxinos G, Watson D. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
26. Polinsky RJ. 1984. Multiple system atrophy. Clinical aspects, pathophysiology, and treatment. Neurol Clin 2:487-498.
27. 2 binding site ligand, in rat brain. Eur J Pharmacol 450:55-60.
28. Robinson ES, Tyacke RJ, Finch L, Willmott G, Husbands S, Nutt DJ, Hudson AL. 2004. Pharmacological characterisation of novel alpha(2)-adrenoceptor antagonists as potential brain imaging agents. Neuropharmacology 46:847-855.
29. Rothman RB, Baumann MH. 2003. Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23-40.
30. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS. 2001. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32-41.
31. Smith A, Nutt D. 1996. Noradrenaline and attention lapses. Nature 380:291.
32. Smith AP, Wilson SJ, Glue P, Nutt DJ. 1992. The effects and after effects of the alpha2-adrenoceptor antagonist idazoxan on mood, memory and attention in normal volunteers. J Psychopharmacol 6:376-381.
33. Thomas DN, Holman RB. 1991. Regulation of endogenous noradrenaline release from rat frontal cortex: a compariosn with the hippocampus. Br J Pharmacol 102:5P.
34. Thomas DN, Nutt D, Holman RB. 1994. Regionally specific changes in extracellular noradrenaline following chronic idazoxan as revealed by in vivo microdialysis. 261:53-57.
35. Tollefson GD. 1983. Monoamine oxidase inhibitors: a review. J Clin Psychiatry 44:280-288.
36. van Veldhuizen MJ, Feenstra MG, Boer GJ. 1994. Regional differences in the in vivo regulation of the extracellular levels of noradrenaline and its metabolites in rat brain. Brain Res 635:238-248.
37. 2- adrenoceptors. Br J Pharmacol 127:1860-1866.